| Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children HP Haber, A Busch, R Ziebach, M Stern The Lancet 355 (9211), 1239-1240, 2000 | 134 | 2000 |
| Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides HP Haber, A Busch, R Ziebach, S Dette, P Ruck, M Stern Journal of ultrasound in medicine 21 (4), 375-382, 2002 | 128 | 2002 |
| Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice JS Shen, A Busch, TS Day, XL Meng, CI Yu, P Dabrowska-Schlepp, ... Journal of inherited metabolic disease 39 (2), 293-303, 2016 | 113 | 2016 |
| Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease JB Hennermann, L Arash‐Kaps, G Fekete, A Schaaf, A Busch, ... Journal of Inherited Metabolic Disease 42 (3), 527-533, 2019 | 73 | 2019 |
| Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency J Rohr, U Pannicke, M Döring, A Schmitt-Graeff, E Wiech, A Busch, ... Journal of clinical immunology 30 (2), 314-320, 2010 | 65 | 2010 |
| ERCP in infants, children and adolescents is feasible and safe: results from a tertiary care center J Felux, E Sturm, A Busch, E Zerabruck, F Graepler, D Stüker, A Manger, ... United European gastroenterology journal 5 (7), 1024-1029, 2017 | 64 | 2017 |
| Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders S Michelfelder, J Parsons, LL Bohlender, SNW Hoernstein, ... Journal of the American Society of Nephrology 28 (5), 1462-1474, 2017 | 64 | 2017 |
| Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease K Dilger, M Alberer, A Busch, A Enninger, R Behrens, S Koletzko, M Stern, ... Alimentary pharmacology & therapeutics 23 (3), 387-396, 2006 | 48 | 2006 |
| Composition and structure of photosystem I in the moss Physcomitrella patens A Busch, J Petersen, MT Webber-Birungi, M Powikrowska, LMM Lassen, ... Journal of Experimental Botany 64 (10), 2689-2699, 2013 | 47 | 2013 |
| Chronic intestinal failure in children MB Krawinkel, D Scholz, A Busch, M Kohl, LM Wessel, KP Zimmer Deutsches Ärzteblatt International 109 (22-23), 409, 2012 | 41 | 2012 |
| Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome C Urla, J Lieber, F Obermayr, A Busch, R Schweizer, SW Warmann, ... BMC surgery 18 (1), 58, 2018 | 40 | 2018 |
| Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: Double‐blind, placebo‐controlled crossover study in cystic fibrosis R Ziebach, B Pietsch‐Breitfeld, M Bichler, A Busch, J Riethmüller, M Stern Pediatric pulmonology 31 (6), 431-435, 2001 | 37 | 2001 |
| Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis J Riethmueller, A Busch, V Damm, R Ziebach, M Stern Infection 30 (6), 387-391, 2002 | 29 | 2002 |
| Moss-derived human recombinant GAA provides an optimized enzyme uptake in differentiated human muscle cells of Pompe disease S Hintze, S Limmer, P Dabrowska-Schlepp, B Berg, N Krieghoff, A Busch, ... International Journal of Molecular Sciences 21 (7), 2642, 2020 | 24 | 2020 |
| Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity T Tschongov, S Konwar, A Busch, C Sievert, A Hartmann, M Noris, ... Frontiers in Immunology 15, 1383123, 2024 | 13 | 2024 |
| Screening endoscopy contributes to relevant modifications of therapeutic regimen in children with intestinal failure A Busch, E Sturm Journal of Pediatric Gastroenterology and Nutrition 67 (4), 478-482, 2018 | 12 | 2018 |
| Hybrid interventions for catheter placement in pediatric intestinal rehabilitation patients with end-stage venous access L Sieverding, A Busch, J Gesche, G Blumenstock, E Sturm, I Tsiflikas, ... Journal of Pediatric Surgery 53 (3), 553-557, 2018 | 12 | 2018 |
| Optimized intravenous antibiotic treatment with Ceftazidime (thrice daily vs. continuous) and tobramycin (thrice vs. once daily) in CF patients J Riethmueller, P Franke, TW Schroeter, A Claass, A Busch, R Ziebach 24th European Cystic Fibrosis Conference, 6-9, 2001 | 12 | 2001 |
| High incidence of proteinuria in children with chronic intestinal failure under long‐term parenteral nutrition H Billing, A Traunspurger, E Sturm, A Busch Journal of Pediatric Gastroenterology and Nutrition 66 (5), 751-754, 2018 | 10 | 2018 |
| Single‐use processing as a safe and convenient way to develop and manufacture moss‐derived biopharmaceuticals H Niederkrüger, A Busch, P Dabrowska‐Schlepp, N Krieghoff, A Schaaf, ... Single‐Use Technology in Biopharmaceutical Manufacture, 311-318, 2019 | 9 | 2019 |
